Biokin Pharmaceutical Selects Cryoport's Temperature-Controlled Solutions for its Pending Phase I and Phase II trials
CHENGDU, China and SEATTLE and IRVINE, California, March 28, 2019 /PRNewswire/ -- Biokin Pharmaceutical Co. Ltd., ("Biokin Pharma") a leading pharmaceutical company with operations inChina and U.S., and Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperature-co...
2019-03-28 21:04
2817